SinoMab BioScience Limited (HKG:3681)
Hong Kong
· Delayed Price · Currency is HKD 1.930
+0.030 (1.58%)
At close: Mar 10, 2026
SinoMab BioScience Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 101.03 | 61.9 | 203.66 | 345.71 | 562.98 | 810.37 | Upgrade
|
| Short-Term Investments | - | 3.89 | 2.87 | 46.2 | 26.55 | 12.77 | Upgrade
|
| Trading Asset Securities | 42.06 | 44.98 | 30.99 | 30.48 | - | 93.06 | Upgrade
|
| Cash & Short-Term Investments | 143.1 | 110.77 | 237.53 | 422.39 | 589.53 | 916.2 | Upgrade
|
| Cash Growth | -26.56% | -53.36% | -43.77% | -28.35% | -35.66% | -24.12% | Upgrade
|
| Prepaid Expenses | 6.31 | 8.56 | 3.22 | 12.23 | 6.16 | 18.15 | Upgrade
|
| Other Current Assets | 13.88 | 66 | 29.44 | 12.47 | - | - | Upgrade
|
| Total Current Assets | 163.28 | 185.34 | 270.18 | 447.09 | 595.69 | 934.35 | Upgrade
|
| Property, Plant & Equipment | 541.61 | 550.72 | 536.77 | 485.82 | 356.21 | 145.92 | Upgrade
|
| Long-Term Investments | - | - | - | - | 26.93 | 31.9 | Upgrade
|
| Other Intangible Assets | 0.52 | 0.94 | 1.84 | 2.6 | 1.92 | - | Upgrade
|
| Other Long-Term Assets | 16.69 | 16.11 | 38.99 | 72.84 | 60.91 | 17.35 | Upgrade
|
| Total Assets | 722.09 | 753.1 | 847.79 | 1,008 | 1,042 | 1,130 | Upgrade
|
| Accrued Expenses | - | 3.07 | 5.93 | 11.36 | 7.85 | 1.75 | Upgrade
|
| Current Portion of Long-Term Debt | 105.16 | 112.64 | 66.59 | 30.42 | 5 | 5 | Upgrade
|
| Current Portion of Leases | 12.64 | 12.94 | 4.66 | 15.38 | 7.39 | 9.13 | Upgrade
|
| Current Unearned Revenue | - | - | 0.3 | 0.3 | 1.55 | 1.55 | Upgrade
|
| Other Current Liabilities | 70.69 | 74.85 | 95.17 | 129.93 | 76.57 | 41.38 | Upgrade
|
| Total Current Liabilities | 188.49 | 203.5 | 172.65 | 187.39 | 98.36 | 58.8 | Upgrade
|
| Long-Term Debt | 249.21 | 306.65 | 324.81 | 238.36 | 193.78 | 55.46 | Upgrade
|
| Long-Term Leases | 41.11 | 50.04 | 54.75 | 73.02 | 69.29 | 28.25 | Upgrade
|
| Total Liabilities | 478.8 | 560.19 | 552.2 | 498.77 | 361.43 | 142.51 | Upgrade
|
| Common Stock | 1,898 | 1,790 | 1,725 | 1,725 | 1,679 | 1,679 | Upgrade
|
| Retained Earnings | -1,725 | -1,675 | -1,490 | -1,247 | -962.96 | -674.77 | Upgrade
|
| Comprehensive Income & Other | 70.15 | 78.19 | 60.6 | 31.48 | -35.94 | -17.35 | Upgrade
|
| Shareholders' Equity | 243.29 | 192.91 | 295.58 | 509.58 | 680.23 | 987.01 | Upgrade
|
| Total Liabilities & Equity | 722.09 | 753.1 | 847.79 | 1,008 | 1,042 | 1,130 | Upgrade
|
| Total Debt | 408.11 | 482.27 | 450.81 | 357.18 | 275.46 | 97.84 | Upgrade
|
| Net Cash (Debt) | -265.02 | -371.5 | -213.28 | 65.2 | 314.07 | 818.36 | Upgrade
|
| Net Cash Growth | - | - | - | -79.24% | -61.62% | -29.07% | Upgrade
|
| Net Cash Per Share | -0.24 | -0.35 | -0.21 | 0.07 | 0.32 | 0.81 | Upgrade
|
| Filing Date Shares Outstanding | 1,205 | 1,092 | 1,035 | 1,035 | 1,006 | 1,006 | Upgrade
|
| Total Common Shares Outstanding | 1,205 | 1,092 | 1,035 | 1,035 | 1,006 | 1,006 | Upgrade
|
| Working Capital | -25.21 | -18.16 | 97.54 | 259.7 | 497.32 | 875.55 | Upgrade
|
| Book Value Per Share | 0.20 | 0.18 | 0.29 | 0.49 | 0.68 | 0.98 | Upgrade
|
| Tangible Book Value | 242.77 | 191.98 | 293.74 | 506.98 | 678.31 | 987.01 | Upgrade
|
| Tangible Book Value Per Share | 0.20 | 0.18 | 0.28 | 0.49 | 0.67 | 0.98 | Upgrade
|
| Machinery | - | 67.2 | 66.4 | 58.61 | 47.02 | 20.73 | Upgrade
|
| Construction In Progress | - | 453.07 | 419.14 | 336.16 | 197.47 | 74.44 | Upgrade
|
| Leasehold Improvements | - | 28.48 | 28.37 | 33.42 | 29.81 | 17.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.